Housed within the Icahn School of Medicine at Mount Sinai, the Milton and Carroll Petrie Department of Urology has locations throughout New York City, Westchester County, and Long Island. Our dedication to breakthrough research, exceptional education, and innovative patient care has long established us as pioneers in the field.

Every day, we provide a spectrum of comprehensive urologic services that showcase our surgical expertise and achieve exceptional patient outcomes. We are equally committed to enhancing access to expert care in underserved communities, and the Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening Unit, embodies the Department’s dedication to this goal. This initiative, generously supported by a $4 million donation from Robert F. Smith, has already had a significant impact: to date, the screening unit has served more than 9,000 patients. This endeavor is now poised for national expansion, bringing accessible prostate cancer screening to communities across the United States.

In the realm of surgical innovation, our Comprehensive Prostate Cancer Program is steered by world-renowned experts. The program includes active surveillance, focal therapy, targeted MRI-guided biopsies, radiation therapy, robotic and open surgery, pathology, medical oncology, precision medicine, and sexual and urinary rehabilitation. We are proud to manage one of the largest active surveillance cohorts nationwide, which focuses on distinguishing aggressive from indolent cancers, and thereby minimizes over-treatment for thousands of patients.

Our other care programs also regularly push the boundaries of what is possible for patients. Our Center for Transgender Medicine and Surgery's Gender Affirmation Program has achieved significant success, helping many individuals through their transformative journeys by uniting innovative surgical techniques with premier patient care. Our Bladder Cancer Program has enjoyed similar success by offering enhanced robotic cystectomies. Developed in collaboration with our anesthesiologists, this surgical approach utilizes nerve blocks for an opioid-free post-surgery recovery, resulting in reduced pain and shorter hospital stays for our patients.

Our deep commitment to translational research spans genomics, targeted drug therapies, precision urology, system biology, imaging, outcomes, robotic surgery, and computer-based decision models. Within our research spaces, we foster a multidisciplinary research community that includes PhDs, MDs, and MPHs, emerging researchers and animal studies investigators. We also provide extensive research opportunities for medical students, residents, and undergraduates, including a summer rotation in our innovative Robotic Simulator Program.

Our residents, chosen for their exceptional talents, often advance to prestigious fellowships, which reflects our collective dedication to continuous education and professional development. Our faculty members encompass educators, researchers, and clinicians with advanced fellowship training in virtually every urologic subspecialty. Uniquely, our Department also includes a behavioral health scientist, who explores the psychosocial impact of cancer, and is developing supportive programs for patients facing their most challenging times.

As the Chair of the Department of Urology, I am honored to guide a team that embodies excellence at every level: in patient care, education, and research. With an emphasis on fostering a fulfilling environment for our faculty, staff, and students, our goal remains providing compassionate care—and extraordinary clinical outcomes—for all our patients.

Ash Tewari, MBBS, MCh, FRCS (Hon.), DSc (Hon.)
Chair of Urology, Mount Sinai Hospital
Director of Center of Excellence for Prostate Cancer at the Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
Surgeon-in-Chief of the Tisch
Cancer Hospital at The Mount Sinai Hospital